All Online

1 - 5 of 5 results

Refine

Active filters

Controlled Substances
0.5 CME CREDIT

This lecture will focus on the problem of chronic pain, its burden on the patient, and the societal consequences that result from mismanagement. The faculty will present strategies for pharmacologic (opioid and non-opioid) and nonpharmacologic management of chronic pain and the evidence behind them. With improved insight into controlling and managing opioid therapy as well as medication-assisted treatment for opioid use disorder, you can help protect your patients from the opioid epidemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020, and they are subject to change as new information is published.


0.75 CME CREDIT

This lecture will focus on the problem of chronic pain, its burden on the patient, and the societal consequences that result from mismanagement. The faculty will present strategies for pharmacologic (opioid and non-opioid) and nonpharmacologic management of chronic pain and the evidence behind them. With improved insight into controlling and managing opioid therapy as well as medication-assisted treatment for opioid use disorder, you can help protect your patients from the opioid epidemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020, and they are subject to change as new information is published.


0.287 CME CREDIT

Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


0.368 CME CREDIT

Pain Points: Best Practices for Tapering of Opioids

0.25 CME/MOC
0.37 AANP | 0.37 Pharmacology

Do you have questions about how to approach tapering opioid medications? Join neurologist and pain specialist, Dr. Charles Argoff, as he reviews a recent expert consensus statement published in Mayo Clinic Proceedings that provides guidance to clinicians about safe opioid tapering. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published. /


0.275 CME CREDIT

Join neurologist and pain specialist, Dr. Charles Argoff, as he discusses a recent expert consensus on best practices in performing a pain assessment—including appropriate components of the physical exam—via telemedicine. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 2/20/2021 and they are subject to change as new information is published.